Company Overview of Precision Nanosystems, Inc.
Precision Nanosystems, Inc. develops tools and processes for the development and manufacture of nanoparticles for use as medicines and in medical research. It offers NanoAssemblr benchtop instrument for prototyping of nanoparticles, as well as for the development of nanoparticle based drugs delivering RNA, small-molecule, and protein therapeutics. The company also provides Neuro9Kit for the study of gene function in neurons and glia cells, as well as potent delivery to primary cells; Test9Kit for the study of gene function in various cell types; and Hepato9Kit for the study of gene function in the liver. In addition, it provides instruments, reagents, and services to life sciences researcher...
402 – 6190 Agronomy Road
Vancouver, BC V6T 1Z3
Founded in 2010
Key Executives for Precision Nanosystems, Inc.
Co-Founder and Chief Executive Officer
Co-Founder and Chief Operating Officer
Compensation as of Fiscal Year 2017.
Precision Nanosystems, Inc. Key Developments
Precision Nanosystems, Inc. Presents at BIO International Conference 2017, Jun-22-2017 09:00 AM
May 27 17
Precision Nanosystems, Inc. Presents at BIO International Conference 2017, Jun-22-2017 09:00 AM. Venue: San Diego Convention Center, San Diego, CA 2865, United States. Speakers: Euan Ramsay, Co-Founder and Chief Operating Officer.
Precision NanoSystems Announces Opening of its New Corporate Headquarters in Vancouver, British Columbia
Oct 6 16
Precision NanoSystems announced the opening of its new corporate headquarters in Vancouver, British Columbia. The custom-designed, 20,000 square foot facility fully integrates the company's functions to enhance product and service offerings to customers. The single location houses R&D, product development, contract manufacturing, technical support, sales and marketing, and business development functions. The facility is designed to promote synergy between PNI's multidisciplinary technical and commercial teams with a focus on maximizing customer benefit from the NanoAssemblr™ product suite.
Precision NanoSystems, Inc. Launches its NanoAssemblr Blaze™ System
Aug 18 16
Precision NanoSystems, Inc. launched its NanoAssemblr Blaze™ system. The NanoAssemblr Blaze from Precision NanoSystems allows for the seamless translation of nanomedicines from discovery to clinical development. The Blaze can manufacture between 10 mL and 1 L per batch. The NanoAssemblr Blaze moves nanomedicine development from the preliminary stages of formulation screening and iteration onto large batch manufacturing of nanoparticles suitable for toxicology screening and analysis. Based on the proven NanoAssemblr platform, the increase in volume afforded by the Blaze provides a seamless transition without further process development. The NanoAssemblr Blaze utilizes the latest microfluidic technology with continuous flow pumping through a proprietary microfluidic cartridge to produce large volumes of identical nanoparticles, between 10 mL and 1 L per batch. The process ensures the self-assembly of uniform particles with controllable and reproducible results.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|